Location: Home
  • search
  • go
  • Relate News
  • 11/11/2025Innovent and SanegeneBio Present Positive Phase 1 Data for siRNA Thera...
  • 11/11/2025SanegeneBio and Eli Lilly Form RNAi Collaboration in Metabolic Disease...
  • 11/11/2025Summit and Akeso Report Positive Phase III Results for Ivonescimab at ...
  • 11/11/2025Nona and Umoja Expand Partnership to Advance In‑Vivo CAR‑T Cell Ther...
  • 11/11/2025China Approves CPEB's Pediatric CAR‑T Therapy for r/r B‑ALL
  • 11/11/20253SBio Presents Encouraging Phase 2 Results for SSGJ‑707 at SITC 2025
  • 11/11/2025Glenmark Gains NMPA Approval for RYALTRIS®
  • 11/11/2025Simcere to Manufacture Idorsia's Insomnia Drug in China
  • 11/11/2025China Launches National Strategy to Integrate AI Across Healthcare Sys...
  • 11/11/2025Zydus Receives China NMPA Approval for Venlafaxine ER Capsules
  • 11/11/2025Chinese Innovative Drug Companies Report Strong Q3 Results
  • 11/11/2025CDE Opens Public Consultation on Draft Guidelines for Recombinant Mono...
  • 11/11/2025CDE Reopens Consultation on Influenza Vaccine Clinical Trial Guideline...
  • 11/11/2025CDE Solicits Comments on Revised HPV Vaccine Clinical Trial Guidelines
  • 11/11/2025CDE Issues Technical Guidelines for Pharmaceutical Research and Evalua...
  • 11/11/2025CDE Seeks Feedbacks on Clinical Trial Guidelines for Adhesion and Irri...
  • 11/7/2025Correctseq Reports World's First Gene-Editing Treatment for Hyperlipid...
  • 11/7/2025Sanofi's Cablivi Wins Approval in China as First Nanobody Therapy for ...
  • 11/7/2025CARsgen Reports Positive Results for Allogeneic CAR-T Therapies CT0596...
  • 11/7/2025Lepu to Present Promising Phase II Data of CD20 ADC MRG001 Plus Orelab...
  • 11/7/2025Vigonvita Life Sciences Debuts on HKSE
  • 11/7/2025UniXell Secures CNY 100M in Series A+ Financing to Advance Stem Cell ...
  • 11/7/2025NMPA Pilots Streamlined Review Pathway for Supplemental Applications o...
  • 11/7/2025Recent Executive Moves
  • 11/6/2025BrightGene Advances Metabolic Drug Pipeline as It Files for Hong Kong ...
  • 11/6/2025Suzhou Ribo Life Science Files for Hong Kong IPO as siRNA Pipeline Adv...
  • 11/6/2025Dermavon Files for Hong Kong IPO to Advance Innovative Skin Health Por...
  • 11/6/2025Novartis Wins China Approval for Two Pluvicto Indications
  • 11/6/2025China Grants Conditional Approval for ACEA's COVID-19 Antiviral Olgotr...
  • 11/6/2025Ivacta Raises CNY 100M+ in Angel Round Led by Qiming Venture Partners
  • Page:24/822 Total number of articles:24650: [First][<<] [22] [23] [24] [25] [26] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group